BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38329740)

  • 61. Macular Telangiectasia Type 2: A Classification System Using MultiModal Imaging MacTel Project Report Number 10.
    Chew EY; Peto T; Clemons TE; Sallo FB; Pauleikhoff D; Leung I; Jaffe GJ; Heeren TFC; Egan CA; Charbel Issa P; Balaskas K; Holz FG; Gaudric A; Bird AC; Friedlander M
    Ophthalmol Sci; 2023 Jun; 3(2):100261. PubMed ID: 36846105
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinician-Driven AI: Code-Free Self-Training on Public Data for Diabetic Retinopathy Referral.
    Korot E; Gonçalves MB; Huemer J; Beqiri S; Khalid H; Kelly M; Chia M; Mathijs E; Struyven R; Moussa M; Keane PA
    JAMA Ophthalmol; 2023 Nov; 141(11):1029-1036. PubMed ID: 37856110
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography.
    Chhablani J; Mithal K; Rao H; Narayanan R
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):549-53. PubMed ID: 24150706
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Two years outcomes of treating full-thickness macula hole associated with idiopathic macular telangiectasia type 2 by internal limiting membrane inverted flap technique: Case reports.
    Nishiyama S; Iwase T
    Medicine (Baltimore); 2021 Sep; 100(36):e27078. PubMed ID: 34516496
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Progression characteristics of ellipsoid zone loss in macular telangiectasia type 2.
    Pauleikhoff D; Bonelli R; Dubis AM; Gunnemann F; Rothaus K; Charbel Issa P; Heeren TF; Peto T; Clemons TE; Chew EY; Bird AC; Sallo FB;
    Acta Ophthalmol; 2019 Nov; 97(7):e998-e1005. PubMed ID: 30968592
    [TBL] [Abstract][Full Text] [Related]  

  • 66. "En face" OCT imaging of the IS/OS junction line in type 2 idiopathic macular telangiectasia.
    Sallo FB; Peto T; Egan C; Wolf-Schnurrbusch UE; Clemons TE; Gillies MC; Pauleikhoff D; Rubin GS; Chew EY; Bird AC;
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6145-52. PubMed ID: 22899757
    [TBL] [Abstract][Full Text] [Related]  

  • 67. OCT Angiography and Ellipsoid Zone Mapping of Macular Telangiectasia Type 2 From the AVATAR Study.
    Runkle AP; Kaiser PK; Srivastava SK; Schachat AP; Reese JL; Ehlers JP
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3683-3689. PubMed ID: 28727884
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epiretinal Membrane Detection at the Ophthalmologist Level using Deep Learning of Optical Coherence Tomography.
    Lo YC; Lin KH; Bair H; Sheu WH; Chang CS; Shen YC; Hung CL
    Sci Rep; 2020 May; 10(1):8424. PubMed ID: 32439844
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Using Deep Learning and Transfer Learning to Accurately Diagnose Early-Onset Glaucoma From Macular Optical Coherence Tomography Images.
    Asaoka R; Murata H; Hirasawa K; Fujino Y; Matsuura M; Miki A; Kanamoto T; Ikeda Y; Mori K; Iwase A; Shoji N; Inoue K; Yamagami J; Araie M
    Am J Ophthalmol; 2019 Feb; 198():136-145. PubMed ID: 30316669
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Low-Shot Deep Learning of Diabetic Retinopathy With Potential Applications to Address Artificial Intelligence Bias in Retinal Diagnostics and Rare Ophthalmic Diseases.
    Burlina P; Paul W; Mathew P; Joshi N; Pacheco KD; Bressler NM
    JAMA Ophthalmol; 2020 Oct; 138(10):1070-1077. PubMed ID: 32880609
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Swept source optical coherence tomography analysis of choroidal thickness in macular telangiectasia type 2: a case-control study.
    Kumar V; Kumawat D; Kumar P
    Graefes Arch Clin Exp Ophthalmol; 2019 Mar; 257(3):567-573. PubMed ID: 30560414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Automated detection of exudative age-related macular degeneration in spectral domain optical coherence tomography using deep learning.
    Treder M; Lauermann JL; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):259-265. PubMed ID: 29159541
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characteristics and quantification of vascular changes in macular telangiectasia type 2 on optical coherence tomography angiography.
    Chidambara L; Gadde SG; Yadav NK; Jayadev C; Bhanushali D; Appaji AM; Akkali M; Khurana A; Shetty R
    Br J Ophthalmol; 2016 Nov; 100(11):1482-1488. PubMed ID: 26823394
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?
    Kelkar AS; Kelkar JA; Tidke S; Agarwal A; Bolisetty M; Kelkar S
    Indian J Ophthalmol; 2021 Dec; 69(12):3570-3576. PubMed ID: 34826997
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Deep virtual adversarial self-training with consistency regularization for semi-supervised medical image classification.
    Wang X; Chen H; Xiang H; Lin H; Lin X; Heng PA
    Med Image Anal; 2021 May; 70():102010. PubMed ID: 33677262
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cross-Attention Based Multi-Resolution Feature Fusion Model for Self-Supervised Cervical OCT Image Classification.
    Wang Q; Chen K; Dou W; Ma Y
    IEEE/ACM Trans Comput Biol Bioinform; 2023; 20(4):2541-2554. PubMed ID: 37027657
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Performance of Automated Machine Learning for Diabetic Retinopathy Image Classification from Multi-field Handheld Retinal Images.
    Jacoba CMP; Doan D; Salongcay RP; Aquino LAC; Silva JPY; Salva CMG; Zhang D; Alog GP; Zhang K; Locaylocay KLRB; Saunar AV; Ashraf M; Sun JK; Peto T; Aiello LP; Silva PS
    Ophthalmol Retina; 2023 Aug; 7(8):703-712. PubMed ID: 36924893
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence and Predictability of Low-Yield Inpatient Laboratory Diagnostic Tests.
    Xu S; Hom J; Balasubramanian S; Schroeder LF; Najafi N; Roy S; Chen JH
    JAMA Netw Open; 2019 Sep; 2(9):e1910967. PubMed ID: 31509205
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
    Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
    Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity.
    Srinivasan R; Teussink MM; Sloan KR; Bharat RPK; Narayanan R; Raman R
    BMC Ophthalmol; 2022 Jun; 22(1):264. PubMed ID: 35698056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.